HUP0302751A2 - Kombinált 5-HT1A receptor agonista és szerotonin újrafelvételt gátló hatású vegyületek új alkalmazásai - Google Patents
Kombinált 5-HT1A receptor agonista és szerotonin újrafelvételt gátló hatású vegyületek új alkalmazásaiInfo
- Publication number
- HUP0302751A2 HUP0302751A2 HU0302751A HUP0302751A HUP0302751A2 HU P0302751 A2 HUP0302751 A2 HU P0302751A2 HU 0302751 A HU0302751 A HU 0302751A HU P0302751 A HUP0302751 A HU P0302751A HU P0302751 A2 HUP0302751 A2 HU P0302751A2
- Authority
- HU
- Hungary
- Prior art keywords
- combined
- serotonin reuptake
- reuptake inhibitors
- novel uses
- butyl
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title 1
- 239000003772 serotonin uptake inhibitor Substances 0.000 title 1
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 4
- 230000003542 behavioural effect Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- BPSWBRVXRVOQSP-UHFFFAOYSA-N 3-[4-[4-(4-cyanophenyl)piperazin-1-yl]butyl]-1h-indole-5-carbonitrile Chemical compound C1=CC(C#N)=CC=C1N1CCN(CCCCC=2C3=CC(=CC=C3NC=2)C#N)CC1 BPSWBRVXRVOQSP-UHFFFAOYSA-N 0.000 abstract 1
- 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 abstract 1
- 101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 125000004533 benzofuran-5-yl group Chemical group O1C=CC2=C1C=CC(=C2)* 0.000 abstract 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 239000000018 receptor agonist Substances 0.000 abstract 1
- 229940044601 receptor agonist Drugs 0.000 abstract 1
- 229940076279 serotonin Drugs 0.000 abstract 1
- 230000000472 traumatic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
Abstract
A találmány kombinált szelektív szerotonin (5-HT) újrafelvételt gátló(SSRI) és 5-HT1A receptor agonista hatású vegyületek alkalmazására,elsősorban 1-[4-(5-cianoindol-3-il)butil]-4-(2-karbamoil-benzofurán-5-il)-piperazin és fiziológiailag elfogadható sói, valamint 3-{4-[4-(4-cianofenil)piperazin-1-il]butil}-1H-indol-5-karbonitril ésfiziológiailag elfogadható sói alkalmazására vonatkozik, mégpedigolyan gyógyszerkészítmények előállítására, amelyek azállatgyógyászatban alkalmazhatók, viselkedési stresszforrásokkaltársult, állatok önmagukra irányuló traumás rendellenességei ésviselkedési stresszforrásokkal társult, kényszerképzetesrendellenességei kezelésére. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00124815 | 2000-11-14 | ||
| PCT/EP2001/011952 WO2002040024A1 (en) | 2000-11-14 | 2001-10-16 | Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0302751A2 true HUP0302751A2 (hu) | 2003-11-28 |
| HUP0302751A3 HUP0302751A3 (en) | 2007-06-28 |
Family
ID=8170369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0302751A HUP0302751A3 (en) | 2000-11-14 | 2001-10-16 | Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20040082594A1 (hu) |
| EP (1) | EP1333832B1 (hu) |
| JP (1) | JP2004513924A (hu) |
| KR (1) | KR20030059244A (hu) |
| CN (1) | CN1222291C (hu) |
| AR (1) | AR031335A1 (hu) |
| AU (2) | AU1502702A (hu) |
| BR (1) | BR0115296A (hu) |
| CA (1) | CA2428511C (hu) |
| CZ (1) | CZ302484B6 (hu) |
| DE (1) | DE60131675T2 (hu) |
| ES (1) | ES2296820T3 (hu) |
| HK (1) | HK1060697A1 (hu) |
| HU (1) | HUP0302751A3 (hu) |
| MX (1) | MXPA03004166A (hu) |
| NO (1) | NO20032148D0 (hu) |
| PL (1) | PL204331B1 (hu) |
| RU (1) | RU2288719C2 (hu) |
| SK (1) | SK287337B6 (hu) |
| UA (1) | UA79583C2 (hu) |
| WO (1) | WO2002040024A1 (hu) |
| ZA (1) | ZA200304606B (hu) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10305739A1 (de) * | 2003-02-11 | 2004-08-19 | Merck Patent Gmbh | Benzofuranderivate |
| BRPI0417858B1 (pt) | 2003-12-23 | 2017-10-10 | H. Lundbeck A/S | Derivative compounds of aniline and pharmaceutical composition that understand it |
| WO2005094896A2 (en) * | 2004-03-26 | 2005-10-13 | Baylor University | Targeted serotonin reuptake inhibitors |
| AR052308A1 (es) | 2004-07-16 | 2007-03-14 | Lundbeck & Co As H | Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto |
| WO2006034788A1 (en) * | 2004-09-28 | 2006-04-06 | Merck Patent Gmbh | Combinations of n-(indolecarbonyl-)piperazine derivatives and serotonin reuptake inhibitors |
| US7629473B2 (en) | 2005-06-17 | 2009-12-08 | H. Lundbeck A/S | 2-(1H-indolylsulfanyl)-aryl amine derivatives |
| AR054393A1 (es) | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos. |
| WO2008017491A1 (en) * | 2006-08-11 | 2008-02-14 | Dsm Ip Assets B.V. | Ligustilide derivatives for the treatment of disorders of the central nervous system |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4333254A1 (de) * | 1993-09-30 | 1995-04-06 | Merck Patent Gmbh | Piperidine und Piperazine |
| DE19512639A1 (de) * | 1995-04-05 | 1996-10-10 | Merck Patent Gmbh | Benzonitrile und -fluoride |
| DE19637237A1 (de) * | 1996-09-13 | 1998-03-19 | Merck Patent Gmbh | Piperazin-Derivate |
| DE19730989A1 (de) * | 1997-07-18 | 1999-01-21 | Merck Patent Gmbh | Piperazin-Derivate |
| CA2338209A1 (en) * | 1998-07-20 | 2000-02-03 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Biphenyl derivatives |
-
2001
- 2001-10-16 AU AU1502702A patent/AU1502702A/xx active Pending
- 2001-10-16 ES ES01983555T patent/ES2296820T3/es not_active Expired - Lifetime
- 2001-10-16 JP JP2002542397A patent/JP2004513924A/ja active Pending
- 2001-10-16 CA CA002428511A patent/CA2428511C/en not_active Expired - Fee Related
- 2001-10-16 AU AU2002215027A patent/AU2002215027B2/en not_active Ceased
- 2001-10-16 MX MXPA03004166A patent/MXPA03004166A/es active IP Right Grant
- 2001-10-16 PL PL360310A patent/PL204331B1/pl not_active IP Right Cessation
- 2001-10-16 RU RU2003115431/15A patent/RU2288719C2/ru not_active IP Right Cessation
- 2001-10-16 BR BR0115296-3A patent/BR0115296A/pt not_active Application Discontinuation
- 2001-10-16 EP EP01983555A patent/EP1333832B1/en not_active Expired - Lifetime
- 2001-10-16 CZ CZ20031433A patent/CZ302484B6/cs not_active IP Right Cessation
- 2001-10-16 SK SK638-2003A patent/SK287337B6/sk not_active IP Right Cessation
- 2001-10-16 HU HU0302751A patent/HUP0302751A3/hu unknown
- 2001-10-16 KR KR10-2003-7006473A patent/KR20030059244A/ko not_active Application Discontinuation
- 2001-10-16 UA UA2003065408A patent/UA79583C2/uk unknown
- 2001-10-16 US US10/416,573 patent/US20040082594A1/en not_active Abandoned
- 2001-10-16 CN CNB018188591A patent/CN1222291C/zh not_active Expired - Fee Related
- 2001-10-16 DE DE60131675T patent/DE60131675T2/de not_active Expired - Lifetime
- 2001-10-16 WO PCT/EP2001/011952 patent/WO2002040024A1/en active IP Right Grant
- 2001-11-14 AR ARP010105299A patent/AR031335A1/es unknown
-
2003
- 2003-05-13 NO NO20032148A patent/NO20032148D0/no not_active Application Discontinuation
- 2003-06-12 ZA ZA200304606A patent/ZA200304606B/en unknown
-
2004
- 2004-05-25 HK HK04103692A patent/HK1060697A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03004166A (es) | 2003-09-22 |
| US20040082594A1 (en) | 2004-04-29 |
| SK287337B6 (sk) | 2010-07-07 |
| CZ302484B6 (cs) | 2011-06-08 |
| AU1502702A (en) | 2002-05-27 |
| BR0115296A (pt) | 2003-09-02 |
| WO2002040024A1 (en) | 2002-05-23 |
| HK1060697A1 (en) | 2004-08-20 |
| HUP0302751A3 (en) | 2007-06-28 |
| ES2296820T3 (es) | 2008-05-01 |
| UA79583C2 (en) | 2007-07-10 |
| CN1474691A (zh) | 2004-02-11 |
| DE60131675T2 (de) | 2008-11-20 |
| KR20030059244A (ko) | 2003-07-07 |
| CA2428511C (en) | 2009-12-29 |
| DE60131675D1 (de) | 2008-01-10 |
| AR031335A1 (es) | 2003-09-17 |
| AU2002215027B2 (en) | 2006-10-05 |
| EP1333832B1 (en) | 2007-11-28 |
| SK6382003A3 (en) | 2003-11-04 |
| PL360310A1 (en) | 2004-09-06 |
| RU2288719C2 (ru) | 2006-12-10 |
| CA2428511A1 (en) | 2002-05-23 |
| PL204331B1 (pl) | 2010-01-29 |
| NO20032148L (no) | 2003-05-13 |
| CZ20031433A3 (cs) | 2003-09-17 |
| JP2004513924A (ja) | 2004-05-13 |
| CN1222291C (zh) | 2005-10-12 |
| EP1333832A1 (en) | 2003-08-13 |
| NO20032148D0 (no) | 2003-05-13 |
| ZA200304606B (en) | 2004-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO341591B1 (no) | 3-Z-[1-(4-(N-((4-metyl-piperazin-1-yl)-metylkarbonyl)-N-metyl-amino)-anilino)-1-fenyl-metylen]-6-metoksykarbonyl-2-indolinon, tautomerene, diastereomerene, enantiomerene, blandinger derav og saltene derav, og i kombinasjon med en ytterligere farmakologisk aktiv substans, for anvendelse i forebygging eller behandling av fibrose ved revmatoid artritt | |
| ATE449090T1 (de) | Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren | |
| AP2002002481A0 (en) | Biaryl ether derivatives useful as monoamine reuptake inhibitors. | |
| NO20061562L (no) | Anvendelse av 1- [4-(5-cyanindol-3yl)butyl ] -4-(2-karbamoylbenzofuran-5-yl)-piperazin og dets fysiologisk akseptable salter | |
| EA200901514A1 (ru) | Новая сольватная и кристаллическая форма производных карбамоилциклогексана | |
| NO20063620L (no) | Arylanilinderivater som beta2 adrenergiske receptoragonister | |
| PE20050229A1 (es) | Derivados de etinilprolina | |
| NO20080670L (no) | Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister | |
| MY152919A (en) | Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders | |
| ATE402141T1 (de) | Phenäthanolaminderivate zur behandlung von krankheiten der atemwege | |
| HUP0302751A2 (hu) | Kombinált 5-HT1A receptor agonista és szerotonin újrafelvételt gátló hatású vegyületek új alkalmazásai | |
| BRPI0411936A (pt) | composto, processo para a sua preparação, composição farmacêutica que comprende o mesmo, utilização de um composto, métodos para o tratamento e profilaxia de distúrbios do sistema nervoso central, alimentares e obesidade | |
| AU2003287914A8 (en) | Piperidine and pyrrolidine derivatives as antagonists of histamine h3 receptor | |
| NO20045535L (no) | Fremgangsmate for a fremme roykeavvenning | |
| NO20072005L (no) | Nye heterocykliske amider | |
| NO20065835L (no) | Medikamenter som inneholder N-sulfamoyl-N'-arylpiperaziner for profylakse eller behandling av overvekt og beslektede tilstander | |
| PE20010157A1 (es) | Composiciones farmaceuticas que contienen inhibidores de oxido nitrico sintasa, inhibidores selectivos de la recaptacion de la serotonina, antagonistas del receptor nk-1 | |
| DK1861360T3 (da) | Pyrrolidin-derivater som histamin-H3-receptorantagonister | |
| NZ584998A (en) | Cycloalkyloxy-and heterocycloalkyloxypyridine compounds as modulators of the histamine h3 receptor | |
| RU2003115431A (ru) | Новые применения объединенных агонистов 5-нт1а и ингибиторов обратного захвата серотонина | |
| NO20071466L (no) | 3-substituerte-5- og 6-aminoalkyl indol-2-karboksylsyreamider og relaterte analoger som inhibitorer av kaseinkinase IE | |
| IS2712B (is) | Notkun týrósínkínasatálma til að meðhöndla sykursýki | |
| GEP20074225B (en) | Use of carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders | |
| HK1122497A1 (en) | Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders | |
| BR0115434A (pt) | Uso de agonistas de 5-ht1a e inibidores de recaptação de sertonina seletivos combinados |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |